By BY MICHAEL CROWLEY, KATIE THOMAS AND MAGGIE HABERMAN from NYT U.S.
https://ift.tt/2UIlkxw
The president’s advocacy of the anti-malarial drug has created tensions in his administration, and fears among doctors that it could unnecessarily expose patients to risks.
No comments:
Post a Comment